Lung cancer: New pill produces unprecedented results in human trial
Results revealed that 60% of patients on lorlatinib were alive without disease progression five years after treatment
Groundbreaking gene therapy trial allows 5 children born deaf to hear
The patients in the trial suffered from a genetic condition called autosomal recessive deafness 9 (DFNB9), which is caused by a mutation in a gene called OTOF
This 6-year-old is a pioneer in the quest to treat a deadly brain tumor
Callie knows only this: Inside her brain lurks something that isn't supposed to be there
